SynopsisMedical equipment(also known asarmamentarium)is designed to aid in thediagnosis, monitoringortreatmentof medical conditions. The global Diagnostic Equipment market was valued at US$ 45060 million in 2023 and is anticipated to reach US$ 71150 million by 2.....
SynopsisBotulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpos.....
SynopsisSalmonella nucleic acid detection kit is a diagnostic tool for detecting Salmonella, usually based on nucleic acid detection technology. This test detects the presence of Salmonella nucleic acid in a sample, thereby confirming the presence of infection. .....
SynopsisActivins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FSH) release. Activin proteins have a wide range of biological acti.....
SynopsisThe global Molecular Diagnostics Raw Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global healthcare spending contributes to occupy 10% .....
SynopsisAn intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. This devices lasts for 5 to 8 years. These devic.....
SynopsisIn this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites The global Communicable Diseases Drugs market size is expected to reach US$ 68580 million.....
SynopsisEstrostatin phosphate is indicated for use in advanced prostate cancer, especially in patients who are refractory to hormones and who have been shown to have poor efficacy in hormone therapy in the initial treatment. The global Estramustine Phosphate mar.....
SynopsisFactors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth o.....
SynopsisNizatidine is a gastric acid secretion inhibitor developed by Lilai Company in the United States. It was first marketed in the United States in 1987 and its name is Axid. Nizatidine is a potent H2 receptor antagonist. It acts on gastric acid secreting cells, b.....
